U.S. Still Underprepared for Pandemic Threats, CDC Head Says
(Bloomberg) -- The U.S. remains underprepared for major pandemic health threats, the director of the Centers for Disease Control and Prevention told Congress, citing major shortfalls revealed by the coronavirus in state, local and federal authorities' ability to spot and track disease and develop countermeasures.
Congress should invest more money in public health, data modernization and contact tracing, CDC Director Robert Redfield told House lawmakers on Thursday.
“You think we weren't prepared for this, wait until we have a real global threat for our health security,” Redfield said at a hearing of the House Committee on Appropriations, the panel that leads congressional funding of government agencies.
The CDC has long been considered one of the world's preeminent health agencies, and has been a model for other countries setting up similar organizations. But it has come under criticism for reacting slowly to the coronavirus, which has infected more than 1.86 million Americans and killed at least 107,000. While the agency was fast in developing a test, it had significant problems rolling it out around the country and then largely receded from the public face of the Trump administration's response to the virus.
In his testimony, Redfield said the agency is having a hard time tracking the impact of the coronavirus on black Americans, making data modernization crucial. Some states are still collecting data “with pen and pencil,” he said.
“Data is the roadmap. It's fundamentally the key first step that we need to do to address the health disparities,” Redfield said.
The U.S. announced Thursday that it will require testing labs to collect zip code data and demographics including race, ethnicity, sex and age, he said.
The CDC funds as much as 70% of state and local public-health efforts, Redfield said. But significant new preparedness investments are needed, in addition to basic efforts to respond to the coronavirus pandemic.
“That needs to be augmented,” Redfield said. “The cost of nothing isn't nothing. the time to do it is now and get that investment.”
He cited local labs as one key area. While New York's state lab was able to develop its own tests, other states have not done so. Redfield also said that states needed to hire 30,000 to 100,000 contact tracers by September to follow new Covid-19 cases. He said he was hopeful AmeriCorps, a community service program supported by the federal government, would be used to augment the contact-tracing workforce.
Redfield also said masks and face coverings remain an important tool to stop the spread of Covid-19.
“We continue to see this as a critical public health tool,” Redfield said. Responding to questions about large public gathers of unmasked people, he said that, “obviously we're very concerned that our public-health message isn't resonating.”
When asked if the CDC has recommended to the White House that tear gas not be used at demonstrations around the country, since coughing can spread the coronavirus, Redfield said, “We have advocated strongly the ability to have face coverings and masks available to protesters.”
When pushed about tear gas he added, “I'll pass on this comment at the next task force meeting.”
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.